DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Rolofylline
Rolofylline
Annexes to the EMA Annual Report 2009
Myocardial Metabolism in Heart Failure: Purinergic Signalling and Other
Adenosine A1 Receptor Antagonists in Clinical Research and Development Berthold Hocher1,2
Illinois College Jacksonville, Illinois
Heart Failure Guidelines
WO 2011/089216 Al
MK-7418 Prot. No. 301-302 PROTECT 2. Synopsis
In Vivo Pharmacological Profiling in Xenopus Embryos Defines a Subset of A1 Adenosine Receptor-Selective Antagonists with Potent
Diagnosis and Management of Acute Heart Failure
Adenosine Receptor P1 Receptor
Stembook 2018.Pdf
Xanthine Derivatives in the Heart: Blessed Or Cursed?
Modulation of the Arrhythmia Substrate in Cardiovascular Disease
A Complex but Promising Therapeutic Target for Alzheimer's Disease
Adenosine A1 Receptor Antagonist Rolofylline Alleviates Axonopathy Caused by Human Tau ΔK280
115 6 December 2020
Theobromine and Related Methylxanthines As Inhibitors of Primary Amine Oxidase
PROSPER Will Develop Online Tools
Top View
European Public Health Conference 2011 4 T H
Science Manuscript Template
PAC1 Receptor–Mediated Clearance of Tau in Postsynaptic Compartments
Pre-Clinical and Clinical Pharmacokinetic/Pharmacodynamic Evaluations Of
Impact of Admission Liver Stiffness on Long-Term Clinical Outcomes In
Lääkeaineiden Yleisnimet (INN-Nimet) 31.12.2019
2013-Heart-Failure-B
Science Journals
Enpp1 and Osteoblasts
Kdigo Clinical Practice Guideline for Acute Kidney Injury
WHO Drug Information Vol. 22, No. 3, 2008
Screening of a Neuronal Cell Model of Tau Pathology for Therapeutic Compounds
Pharmaabkommen A1 E
Adenosine and Lipids: a Forced Marriage Or a Love Match?
Pharmaceutical Products and Chemical Intermediates, Fourth Review: Advice Concerning the Addition of Certain Products to the Pharmaceutical Appendix to the HTS
KDIGO Clinical Practice Guideline for Acute Kidney Injury
Implications for Drug Discovery
Organic Anion Transporter 2 (OAT2)
The Role of Purinergic Receptors in Stem Cell Differentiation
WO 2016/133803 Al 25 August 2016 (25.08.2016) P O P C T
Trend Analysis of a Database of Intravenous Pharmacokinetic Parameters in Humans for 1352 Drug Compounds
WO 2015/120110 A2 13 August 2015 (13.08.2015) P O P C T
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Effect of Dipyridamole on Atp Metabolism in the Red Blood Cells and Cardiovascular Protection
Antioxidant Activity Elicited by Low Dose of Caffeine Attenuates Pentylenetetrazol-Induced Seizures and Oxidative Damage in Rats
Clinicalkey Drug Monographs
Cell-Type Specific Interrogation of Cea Drd2 Neurons to Identify Targets for 2 Pharmacological Modulation of Fear Extinction
Identifying Subpopulations with Distinct Response To
Organic Anion Transporter 2: an Enigmatic Human Solute Carrier S
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Viewpoint: Paradoxical Excess Mortality in the PLATO Trial Should Be Independently Verified
RLX030/Serelaxin
Novel Agent Eases Acute Heart Failure Symptoms
Pharmacological Targeting of Adenosine Receptor Signaling
WO 2012/166389 Al 6 December 2012 (06.12.2012) P O P C T
Study Protocol
Tinkering with Targeting Nucleotide Signaling for Control of Intracellular
United States Patent (10) Patent No.: US 8,686,184 B2
2008 Corporate Responsibility Report. on Behalf of the Board, I Am Very Pleased to Note THOMAS E
Rolofylline for Acute Heart Failure
The Investigation of Receptor Systems in Isolated Rat Cardiac Fibroblast and Myofibroblast Cells
Focusing on Adenosine Receptors As a Potential Targeted Therapy in Human Diseases
Gα12/13 Signaling in Metabolic Diseases Yoon Mee Yang1,Da-Solkuen2, Yeonseok Chung 2,Hitoshikurose3 and Sang Geon Kim2
39 Vascular News
Targeting the 26S Proteasome to Protect Against Proteotoxic Diseases
INN-Nimet 1 20.8.2019 a Abacavir Abacavirum Abakaviiri
Myocardial Metabolism in Heart Failure: Purinergic Signalling and Other Metabolic Concepts